Olga Benítez Hidalgo: New Evidence on Marstacimab in Hemophilia Care
Olga Benítez Hidalgo, Board of Directors at Spanish Society of Thrombosis and Hemostasis, Hematologist at Vall d’Hebron Barcelona Hospital Campus, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Thrombosis and Haemostasis:
“Published in the Journal of Thrombosis and Haemostasis: phase 3 BASIS study analysis on the management of breakthrough bleeds and surgical procedures in people with hemophilia A or B without inhibitors receiving marstacimab prophylaxis.
As non-factor prophylactic therapies continue to expand the treatment landscape in hemophilia, generating practical evidence for the management of real-world clinical situations – including bleeding episodes and procedures – is essential.
Proud to contribute to this collaborative clinical research effort.”
Title: Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study
Authors: Johnny Mahlangu, Davide Matino, Olga Benítez Hidalgo, Travis Gould, Hae Kyung Kim, Pengling Sun, Carrie Turich Taylor, Andrew Palladino

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering